Feed Preview

Fast Growing

Alzheimer's Disease: RNA Sequencing

Alzheimer's Disease: RNA Sequencing diagram by Liu et al, PLOS One
Liu et al, PLOS One

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

Top 20 most recent papers
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationFebruary 12, 2020
Nicolai FranzmeierMichael Ewers
14
1
Angewandte Chemie

Light-induced chiral FexCuySe nanoparticles prevent β-amyloidopathy in vivo

Angewandte ChemieFebruary 19, 2020
Hua KuangChuanlai Xu
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Spatial navigation ability predicts progression of dementia symptomatology

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationFebruary 12, 2020
Taylor F LevineDenise Head
18
1
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism

Transcriptomic and functional studies reveal undermined chemotactic and angiostimulatory properties of aged microglia during stroke recovery

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and MetabolismFebruary 18, 2020
Lu JiangXiaoming Hu
1
Frontiers in Pharmacology

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer's Disease

Frontiers in PharmacologyFebruary 18, 2020
Soo Youn LeeYoung Hye Kim
2
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Time from diagnosis to institutionalization and death in people with dementia

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationFebruary 20, 2020
Karlijn J JolingHein P J van Hout
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationFebruary 19, 2020
Chengjie XiongJohn C Morris
2
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

Bill Gates funds $10 million grant to Alzheimer's Association to fuel research for Alzheimer's treatment

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationFebruary 8, 2020
1
Cell Reports

Transcriptional Signatures of Tau and Amyloid Neuropathology

Cell ReportsFebruary 13, 2020
Isabel CastanhoJonathan Mill
52
5

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-rna-sequencing/34563c7f-8cf6-4c83-aa4a-c983916648d6